跳至主要内容
临床试验/NCT06592365
NCT06592365招募中不适用

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effects and Safety of Green Tea Extract(GTE) Consumption on Blood Glucose Regulation

Amorepacific Corporation3 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2022年8月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
84
试验地点
3
主要终点
Change in fasting glucose level

研究概览

简要总结

This study was conducted to investigate the effects of green tea extracts on reducing blood glucose level

详细描述

This study was conducted over 12 weeks with a randomized, double-blind, placebo-controlled, parellel design

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
19 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged between 19 to 64 years
  • BMI between 18.5 and 29.9kg/m²
  • fasting blood glucose between 100 and 139 mg/dL (Note: if some subjects with blood glucose range of 126 - 139 mg/dL, those who are taking or requre medication must be excluded to meet ethical standards.)
  • subjects who voluntarily decide to participate in this study and sign the informed consent form.

排除标准

  • Individuals taking to obesity, dyslipidemia, or uncontrolled hypertension at the screening
  • Individuals diagnosed with diabetes and who have taken medications related to blood glucose
  • Individuals congenital enzyme deficiencies related to sugar metabolism.
  • with hypersensitivity to the test food or ingredients(e.g., green tea, caffeine).
  • Individuals ongoing treatment diseases significantly related glucose metabolism.
  • Individuals with a history of surgery significantly related to glucose metabolism within the last 6 months
  • diagnosed with gastrointestinal diseases, cardiovascular diseases, uncontrolled chronic medical conditions, thyroid disorders, or active malignant tumors requiring medication
  • Individuals with liver function impairment or acute or chronic hepatitis or liver cirrhosis
  • Individuals with renal disorder
  • Individuals with a weight change of 5 kg or more within the last 3 months.

结局指标

主要结局

Change in fasting glucose level

时间窗: Baseline, week 12

blood glucose level detection

次要结局

  • changes of indicator of lipid metabolism(Baseline, week 12)
  • OGTT(Baseline, week 12)
  • blood biomarkers(Baseline, week 12)
  • change in waist circumference(cm)(Baseline, week 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验